102	DTP-HepB_vaccine
DTP-HepB vaccine &&&&& Introduction &&&&& &&&&& &&&&& &&&&& '''DTP-HepB vaccine''' is a combination vaccine whose generic name is diphtheria and tetanus toxoids and whole-cell pertussis and hepatitis B (recombinant) vaccine (adsorbed) or DTP-Hep B. It protects against the infectious diseases diphtheria, tetanus, pertussis, and hepatitis B. &&&&& &&&&& A branded formulation, Tritanrix-HepB manufactured by GlaxoSmithKline, was granted marketing approval in the EU in 1996. Marketing approval lapsed in 2014. &&&&& &&&&& A review conducted in 2012 concluded that there was insufficient evidence to determine differences in safety and efficacy between DTP-HepB vaccine and Hib vaccine administered separately and pentavalent DTP-HepB-Hib vaccine. &&&&& &&&&& References &&&&& &&&&& &&&&& &&&&& &&&&& &&&&& &&&&& &&&&& &&&&& &&&&& &&&&& &&&&& &&&&& &&&&& &&&&& 